Genmab | GEN - Stock

Stock Price
1,707.00
Daily Change
-4.00 -0.23%
Monthly
1.10%
Yearly
26.44%
Q2 Forecast
1,628.53

Genmab reported DKK13M in Stock for its fiscal quarter ending in June of 2025.





Stock Change Date
Agios Pharmaceuticals USD 32.92M 886K Dec/2025
Almirall EUR 178.13M 1.54M Dec/2025
Amarin USD 184.7M 13.46M Sep/2025
Amgen USD 6.22B 121M Dec/2025
argenx SE USD 340.62M 66.61M Jun/2025
AstraZeneca USD 6.59B 126M Sep/2025
Bayer EUR 12.33B 221M Sep/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Demant DKK 2.62B 78M Dec/2025
Exelixis USD 27.4M 3.92M Sep/2025
Fresenius Medical Care EUR 2.14B 54.28M Dec/2025
Galapagos EUR 22.95M 15.57M Sep/2025
Genmab DKK 13M 1000K Jun/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
GN Store Nord DKK 2.38B 26M Sep/2025
GRIFOLS EUR 3.35B 213.23M Jun/2025
Hikma Pharmaceutical USD 1.08B 96M Jun/2025
Insmed USD 132.07M 11.1M Dec/2025
Lonza CHF 1.68B 163M Dec/2025
Merck EUR 4.51B 42M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025
UCB EUR 1.31B 173M Dec/2024